Actinium Pharmaceuticals
ATNM
#9342
Rank
A$70.54 M
Marketcap
$2.26
Share price
5.76%
Change (1 day)
-65.59%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2024 (TTM): -A$70.79 Million

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are A$0.08 Million. In 2023 the company made an earning of -A$79.87 Million a decrease over its 2022 earnings that were of -A$52.47 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$70.79 Million-11.37%
2023 -A$79.87 Million52.24%
2022 -A$52.47 Million36.61%
2021 -A$38.41 Million11.48%
2020 -A$34.45 Million1.46%
2019 -A$33.96 Million-7.37%
2018 -A$36.66 Million-11.46%
2017 -A$41.4 Million10.67%
2016 -A$37.41 Million15.7%
2015 -A$32.34 Million-14.86%
2014 -A$37.98 Million129.19%
2013 -A$16.57 Million-8.55%
2012 -A$18.12 Million
2010 A$0.01 M-152.15%
2009 -A$0.03 Million-39.8%
2008 -A$0.05 Million120.29%
2007 -A$0.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$57.22 Million-20.38%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.60 B-938.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.16 Billion 113.75%๐Ÿ‡บ๐Ÿ‡ธ USA